First Online: 13 October 2016
: J.M.-P. is a shareholder of ArthroLab Inc. and consultant for AbbVie, Bioibrica, Ferring, Medapharma, Pierre-Fabre and TRB Chemedica. P.G.C. is a member of the speakers bureau and/or is a consultant for AbbVie, Flexion, Janssen, Lilly, Novartis, Pfizer, Regeneron and Roche. C.C. has received consultancy fees and honoraria from Alliance for Better Bone Health, Amgen, Eli Lilly, GlasoSmithKline, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. J.-P.P. is a shareholder of ArthroLab Inc. and is a consultant for AbbVie, Bioibrica, Centrexion, Ferring, Medapharma, Pfizer, Pierre-Fabre, Teva Pharmaceuticals and TRB Chemedica. All other authors declare no competing interests.